At low-dose gp96, CD11c+CD11b+ cells (cDCs) cross-present HSP-chaperoned peptides, release pro-inflammatory cytokines that promote Th1 immunity and are responsible for the induction of anti-tumour immunity31. The gene discussed is HSP90B2P; the disease is neoplasm.